<html>
<head>PUBMED IDs for OP-2</head>
<body bgcolor='#C5F0F2'><h1>OP-2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/6316257/'>Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins.</a> November 11  1983<br><a href='https://pubmed.ncbi.nlm.nih.gov/1460021/'>Osteogenic protein-2. A new member of the transforming growth factor-beta superfamily expressed early in embryogenesis.</a> December 15  1992<br><a href='https://pubmed.ncbi.nlm.nih.gov/8275473/'>Messenger RNA levels of five genes located at chromosome 11q13 in B-cell tumors with chromosome translocation t(11;14)(q13;q32).</a> January 15  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/9462726/'>Cloning of the murine TROP2 gene: conservation of a PIP2-binding sequence in the cytoplasmic domain of TROP-2.</a> February 14  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10412039/'>Effects of interferon alpha on human osteoprogenitor cell growth and differentiation in vitro.</a> July 21  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/11169457/'>Retroviral marking of human bone marrow fibroblasts: in vitro expansion and localization in calvarial sites after subcutaneous transplantation in vivo.</a> February 13  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12209960/'>Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cells.</a> September 5  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12883998/'>STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human marrow stromal cells and their more differentiated progeny: a comparative investigation in vitro.</a> July 29  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15305371/'>Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.</a> August 12  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/21747412/'>Methotrexate consolidation treatment according to pharmacogenetics of MTHFR ameliorates event-free survival in childhood acute lymphoblastic leukaemia.</a> April 4  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/24741582/'>FcÎ³-receptor IIIA polymorphism p.158F has no negative predictive impact on rituximab therapy with and without sequential chemotherapy in CD20-positive posttransplant lymphoproliferative disorder.</a> January 8  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25164548/'>TROP-2 expression in papillary thyroid cancer: a preliminary cyto-histological study.</a> June 23  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25314782/'>[Successful treatment of a patient with two hematologic tumors: double-hit lymphoma and acute myelomonoblastic leukemia].</a> October 29  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25314777/'>[Heterogeneity of acute myeloid leukemia with the translocation t(8;21)(q22;q22)].</a> October 29  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25314775/'>[Selection of an unrelated donor for hematopoietic stem cell transplantation. HLA haplotypes in patients with blood system diseases].</a> October 29  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25314737/'>New hope for people with migraine headaches.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26481593/'>TROP-2 expression in papillary thyroid carcinoma: Potential Diagnostic Utility.</a> September 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26677438/'>Biomarkers in triple negative breast cancer: A review.</a> December 18  2015<br></body></html>
